HDAC9 and breast cancer: Based on our laboratory results on the triazole–isoxazole hybrid structure and the role of substitute thiouracil on HDACis role, we designed a novel structure and developed an extensive library of compounds that could serve as a base to develop new drugs that target HDAC in BC (Figure 1 and Figure 2).